Subthreshold symptoms and time to relapse/recurrence in a community cohort of bipolar disorder outpatients

• Published in: Journal of affective disorders 2012-12, Vol.143 (1), p.160-165
• Main Authors: De Dios, C, Ezquiaga, E, Agud, J.L, Vieta, E, Soler, B, García-López, A
• Format: Article
• Language: English
• Subjects: Adult and adolescent clinical studies; Affective disorders; Biological and medical sciences; Bipolar affective disorder; Bipolar disorder; Bipolar Disorder - diagnosis; Bipolar Disorder - psychology; Bipolar disorders; Chronic Disease; Cyclothymic Disorder - psychology; Data processing; Disease-Free Survival; Emotional behavior; Female; Follow-up study; Humans; Longitudinal Studies; Male; Medical sciences; Middle Aged; Mood; Mood disorders; Outpatients; Prognosis; Prospective Studies; Psychiatry; Psychology. Psychoanalysis. Psychiatry; Psychometrics; Psychopathology. Psychiatry; Psychosocial factors; Recurrence; Relapse; Retrospective Studies; Social interactions; Spain; Stress; Stress, psychological; Subthreshold symptoms; Survival; Symptoms; Time Factors
• ISSN: 0165-0327; 1573-2517
• DOI: 10.1016/j.jad.2012.05.047

Abstract Background Researchers have previously found that persistent subthreshold symptoms increase the risk and shorten the time until an affective relapse in bipolar disorder (BD) patients. Research has mainly focused on patients from tertiary Care Centers in USA. We tested the hypothesis that even in a different setting, BD outpatients with subsyndromal affective symptoms would re.turn to a subsequent major affective episode significantly faster than completely asymptomatic at baseline. Secondarily, we analysed other variables related to time and risk to relapse. Methods A community cohort of BD outpatients from Madrid (Spain) followed-up in a systematic prospective follow-up protocol for up to five years were evaluated. Patients in clinical euthymia at baseline were included and evaluated quarterly. Results Initially, 225 patients were included in the survival analysis. Of them, according to predefined psychometric criteria, 163 were in euthymia (72.4%) and 62 (27.6%) suffered subsyndromal symptoms. Median follow-up was 157.6 weeks (95% CI, 78.14 to 111); 57.3% of patients experienced at least one affective episode during their follow-up. Median survival time to first affective episode was 109 weeks for patients in euthymia at baseline, versus 35 weeks for those with subsyndromal symptoms (p